Elutia (ELUT) Cash from Financing Activities (2019 - 2026)
Elutia recorded quarterly Cash from Financing Activities of $3000.0 in Q1 2026, up 100.01% quarter-over-quarter from -$23.1 million in Q4 2025, and down 99.98% year-over-year from $13.3 million in Q1 2025.
Elutia's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $3000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 99.98% year-over-year to $3000.0; the TTM figure through Mar 2026 stood at -$23.9 million (down 169.43% YoY), while the FY2025 annual figure was -$10.6 million, down 162.23% from the prior year.
- Cash from Financing Activities came in at $3000.0 for Q1 2026 at Elutia, up from -$23.1 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $14.3 million in Q4 2022 to a low of -$23.1 million in Q4 2025.
- A 5-year average of $1.4 million and a median of -$151000.0 in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 51610.53% in 2024 and plunged 15223.18% in 2025, its largest moves.
- Elutia's Cash from Financing Activities stood at $14.3 million in 2022, then sank by 104.87% to -$695000.0 in 2023, then soared by 78.27% to -$151000.0 in 2024, then slumped by 15223.18% to -$23.1 million in 2025, then surged by 100.01% to $3000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $3000.0, -$23.1 million, and -$262000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | -23.14 Mn |
| Dec 31, 2025 | -23.14 Mn |
| Sep 30, 2025 | -262,000.00 |
| Sep 30, 2025 | -262,000.00 |
| Jun 30, 2025 | -516,000.00 |
| Jun 30, 2025 | -516,000.00 |
| Mar 31, 2025 | 13.28 Mn |
| Mar 31, 2025 | 13.28 Mn |
| Dec 31, 2024 | -151,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Sep 30, 2024 | 11.53 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | 9.79 Mn |
| Jun 30, 2024 | 9.79 Mn |
| Mar 31, 2024 | -4.07 Mn |
| Mar 31, 2024 | -4.07 Mn |
| Dec 31, 2023 | -695,000.00 |
| Dec 31, 2023 | -695,000.00 |
| Sep 30, 2023 | 10.41 Mn |
| Sep 30, 2023 | 10.41 Mn |
| Jun 30, 2023 | -19,000.00 |
| Jun 30, 2023 | -19,000.00 |
| Mar 31, 2023 | 148,000.00 |
| Mar 31, 2023 | 148,000.00 |
| Dec 31, 2022 | 14.27 Mn |
| Dec 31, 2022 | 14.27 Mn |
| Sep 30, 2022 | -2.78 Mn |
| Sep 30, 2022 | -2.78 Mn |
| Jun 30, 2022 | -3.00 Mn |
| Jun 30, 2022 | -3.00 Mn |
| Mar 31, 2022 | -869,000.00 |
| Mar 31, 2022 | -869,000.00 |
| Dec 31, 2021 | 14.21 Mn |
| Dec 31, 2021 | 14.21 Mn |
| Sep 30, 2021 | -2.55 Mn |
| Sep 30, 2021 | -2.55 Mn |
| Jun 30, 2021 | -1.23 Mn |
| Jun 30, 2021 | -1.23 Mn |
| Mar 31, 2021 | -3.73 Mn |
| Mar 31, 2021 | -3.73 Mn |
| Dec 31, 2020 | 43.37 Mn |
| Dec 31, 2020 | 43.37 Mn |
| Sep 30, 2020 | 2.27 Mn |
| Sep 30, 2020 | 2.27 Mn |
| Jun 30, 2020 | 4.43 Mn |
| Jun 30, 2020 | 4.43 Mn |
| Mar 31, 2020 | 1.14 Mn |
| Mar 31, 2020 | 1.14 Mn |
| Dec 31, 2019 | 4.74 Mn |
| Dec 31, 2019 | 4.74 Mn |